La maladie de Parkinson en France (serveur d'exploration) - Curation (PubMed)

Index « MedMesh.i » - entrée « Genetic Vectors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Genetic Variation < Genetic Vectors < Genetics  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000370 (2015) Marie Vandecasteele [France] ; Yann-Suhan Senova [France] ; Stéphane Palfi [France] ; Guillaume P. Dugué [France][Therapeutic potential of optogenetic neuromodulation].
000571 (2014) Stéphane Palfi [France] ; Jean Marc Gurruchaga [France] ; G Scott Ralph [Royaume-Uni] ; Helene Lepetit [France] ; Sonia Lavisse [France] ; Philip C. Buttery [Royaume-Uni] ; Colin Watts [Royaume-Uni] ; James Miskin [Royaume-Uni] ; Michelle Kelleher [Royaume-Uni] ; Sarah Deeley [Royaume-Uni] ; Hirokazu Iwamuro [France] ; Jean Pascal Lefaucheur [France] ; Claire Thiriez [France] ; Gilles Fenelon [France] ; Cherry Lucas [Royaume-Uni] ; Pierre Brugières [France] ; Inanna Gabriel [France] ; Kou Abhay [France] ; Xavier Drouot [France] ; Naoki Tani [France] ; Aurelie Kas [France] ; Bijan Ghaleh [France] ; Philippe Le Corvoisier [France] ; Patrice Dolphin [France] ; David P. Breen [Royaume-Uni] ; Sarah Mason [Royaume-Uni] ; Natalie Valle Guzman [Royaume-Uni] ; Nicholas D. Mazarakis [Royaume-Uni] ; Pippa A. Radcliffe [Royaume-Uni] ; Richard Harrop [Royaume-Uni] ; Susan M. Kingsman [Royaume-Uni] ; Olivier Rascol [France] ; Stuart Naylor [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Pierre Cesaro [France] ; Kyriacos A. Mitrophanous [Royaume-Uni]Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
000599 (2014) M. Anheim [France][Triple-gene therapy in Parkinson disease (ProSavin): toward a putaminal dopamine factory?].
000762 (2013) Erwan Bezard [France] ; Zhenyu Yue ; Deniz Kirik ; Maria Grazia SpillantiniAnimal models of Parkinson's disease: limits and relevance to neuroprotection studies.
000911 (????) Claire Golé [France] ; Romain Reboul ; Pascale Pisano[Gene therapy in Parkinson disease: a promising future treatment?].
000975 (2011) Patrice P. Denèfle [France]Introduction to gene therapy: a clinical aftermath.
000B15 (2009) Béchir Jarraya [France] ; Sabrina Boulet ; G Scott Ralph ; Caroline Jan ; Gilles Bonvento ; Mimoun Azzouz ; James E. Miskin ; Masahiro Shin ; Thierry Delzescaux ; Xavier Drouot ; Anne-Sophie Hérard ; Denise M. Day ; Emmanuel Brouillet ; Susan M. Kingsman ; Philippe Hantraye ; Kyriacos A. Mitrophanous ; Nicholas D. Mazarakis ; Stéphane PalfiDopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia.
000D33 (2007) Delphine Cuchet [France] ; Corinne Potel ; Joélle Thomas ; Alberto L. EpsteinHSV-1 amplicon vectors: a promising and versatile tool for gene delivery.
000D61 (2007) N A Do Thi [France] ; P. Saillour ; L. Ferrero ; T. Paunio ; J. MalletDoes neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?
000E47 (2006) Martine Barkats [France] ; Philippe Horellou ; Philippe Colin ; Stéphanie Millecamps ; Nicole Faucon-Biguet ; Jacques Mallet1-methyl-4-phenylpyridinium neurotoxicity is attenuated by adenoviral gene transfer of human Cu/Zn superoxide dismutase.
000F80 (2004) N A Do Thi [France] ; P. Saillour ; L. Ferrero ; J F Dedieu ; J. Mallet ; T. PaunioDelivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
001197 (2001) M. Giménez Y Ribotta [France]Gene therapy strategies in neurodegenerative diseases.
001473 (1997) P. Horellou [France] ; J. MalletGene therapy for Parkinson's disease.
001477 (1997) A. Bilang-Bleuel [France] ; F. Revah ; P. Colin ; I. Locquet ; J J Robert ; J. Mallet ; P. HorellouIntrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.
001512 (1997) P. Horellou [France] ; A. Bilang-Bleuel ; J. MalletIn vivo adenovirus-mediated gene transfer for Parkinson's disease.
001612 (1994) P. Horellou [France] ; E. Vigne ; M N Castel ; P. Barnéoud ; P. Colin ; M. Perricaudet ; P. Delaère ; J. MalletDirect intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.
001798 (1989) P. Horellou [France] ; B. Guibert ; V. Leviel ; J. MalletRetroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: regulated release of dopamine in mouse anterior pituitary AtT-20 cells.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Genetic Vectors" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Genetic Vectors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Genetic Vectors
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024